{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:23:01Z","timestamp":1787865781425,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Syphilis is a sexually and vertically transmitted infection caused by the bacteria <jats:italic>Treponema pallidum<\/jats:italic> for which there are few proven alternatives to penicillin for treatment. For pregnant women infected with syphilis, penicillin is the only WHO-recommended treatment that will treat the mother and cross the placenta to treat the unborn infant and prevent congenital syphilis. Recent shortages, national level stockouts as well as other barriers to penicillin use call for the urgent identification of alternative therapies to treat pregnant women infected with syphilis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This prospective, randomized, non-comparative trial will enroll non-pregnant women aged 18\u2009years and older with active syphilis, defined as a positive rapid treponemal and a positive non-treponemal RPR test with titer \u22651:16. Women will be randomized in a 2:1 ratio to receive the oral third generation cephalosporin cefixime at a dose of 400\u2009mg two times per day for 10\u2009days (<jats:italic>n<\/jats:italic>\u2009=\u2009140) or benzathine penicillin G 2.4 million units intramuscularly based on the stage of syphilis infection (<jats:italic>n<\/jats:italic>\u2009=\u200970). RPR titers will be collected at enrolment, and at three, six, and nine\u2009months following treatment. Participants experiencing a 4-fold (2 titer) decline by six\u2009months will be considered as having an adequate or curative treatment response.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Demonstration of efficacy of cefixime in the treatment of active syphilis in this Phase 2 trial among non-pregnant women will inform a proposed randomized controlled trial to evaluate cefixime as an alternative treatment for pregnant women with active syphilis to evaluate prevention of congenital syphilis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:bold>Trial identifier:<\/jats:bold> www.Clinicaltrials.gov, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03752112?term=cefixime&amp;cond=syphilis&amp;draw=2&amp;rank=2\">NCT03752112<\/jats:ext-link>. Registration Date: November 22, 2018.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-04980-1","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T12:02:47Z","timestamp":1591790567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra)"],"prefix":"10.1186","volume":"20","author":[{"given":"Melanie M.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Oliveira","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alix Leite","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela Freitas","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica Espinosa","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo Castelo","family":"Branco Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza","family":"Bazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson Fernando","family":"Mendes Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Pereira Giozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena Pamela D\u00edaz","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve B.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndema","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Huong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soe Soe","family":"Thwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Broutet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"issue":"2","key":"4980_CR1","doi-asserted-by":"publisher","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","volume":"14","author":"EL Korenromp","year":"2019","unstructured":"Korenromp EL, Rowley J, Alonso M, Brito de Mello M, Wijesooriya NS, Mahian\u00e9 SG, Ishikawa N, Le LV, Newman-Owiredu M, Nagelkerke N, Newman L, Kamb M, Broutet N, Taylor MM. Global burden of maternal and congenital syphilis and associated adverse birth outcomes \u2013 estimates for 2016 and progress since 2012. PLOS One. 2019;14(2):e0211720.","journal-title":"PLOS One"},{"key":"4980_CR2","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1038\/nrdp.2017.73","volume":"3","author":"R Peeling","year":"2018","unstructured":"Peeling R, Mabey D, Kamb M, Chen XC, Radolf JD, Benzaken AS. Syphilis. Nat Rev Dis Primers. 2018;3:17073. https:\/\/doi.org\/10.1038\/nrdp.2017.73.","journal-title":"Nat Rev Dis Primers"},{"key":"4980_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman LM, Gottlieb S, Thwin SS, Broutet N, Taylor MM. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548\u201362.","journal-title":"Bull World Health Organ"},{"key":"4980_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2471\/BLT.12.107623","volume":"91","author":"GB Gomez","year":"2013","unstructured":"Gomez GB, et al. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:217\u201326 [PubMed: 23476094].","journal-title":"Bull World Health Organ"},{"key":"4980_CR5","volume-title":"WHO guideline on syphilis screening and treatment in pregnant women","author":"WHO","year":"2017","unstructured":"WHO. WHO guideline on syphilis screening and treatment in pregnant women. 2017. https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/syphilis-ANC-screenandtreat-guidelines\/en\/."},{"key":"4980_CR6","unstructured":"WHO. WHO guidelines for the treatment of Treponema pallidum (syphilis). 2016 http:\/\/wwwwhoint\/reproductivehealth\/publications\/rtis\/syphilis-treatment-guidelines\/en\/."},{"key":"4980_CR7","unstructured":"Workowski KA, Bolan GA, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR. 2015;64(RR-03):1\u2013137."},{"issue":"12","key":"4980_CR8","doi-asserted-by":"publisher","first-page":"e1002473","DOI":"10.1371\/journal.pmed.1002473","volume":"14","author":"S Nurse-Findlay","year":"2017","unstructured":"Nurse-Findlay S, Taylor MM, Savage M, Mello MB, Saliyou S, Lavayen M, Seghers F, Campbell ML, Fran\u00e7oise Birgirimana F, Ouedraogo L, Pyne-Mercier L. Supply, demand, and shortages of Benzathine penicillin for treatment of syphilis: a market assessment. PLoS Med. 2017;14(12):e1002473.","journal-title":"PLoS Med"},{"key":"4980_CR9","doi-asserted-by":"crossref","unstructured":"Taylor MM, Zhang X, Nurse-Findlay S, Hedman L, Kiarie J. Global estimates of penicillin need for treatment of syphilis. Bull World Health Organ. 2016;94(8):559\u2013559A.","DOI":"10.2471\/BLT.16.173310"},{"issue":"1","key":"4980_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijantimicag.2015.10.020","volume":"47","author":"Z Liang","year":"2016","unstructured":"Liang Z, Chen YP, Yang CS, Guo W, Jiang XX, Xu XF, et al. Meta-analysis of ceftriaxone compared with penicillin for the treatment of syphilis. Int J Antimicrob Agents. 2016;47(1):6\u201311.","journal-title":"Int J Antimicrob Agents"},{"key":"4980_CR11","doi-asserted-by":"publisher","unstructured":"Cao Y, Su X, Wang Q, Xue H, Zhu X, Zhang C, et al. A multicenter study evaluating ceftriaxone and benzathine penicillin G as treatment agents for early syphilis in Jiangsu, China. Clin Infect Dis. 2017;65(10):1683\u20138. https:\/\/doi.org\/10.1093\/cid\/cix611.","DOI":"10.1093\/cid\/cix611"},{"key":"4980_CR12","unstructured":"Norris SJ, Cox DL, Weinstock GM. Biology of Treponema pallidum: correlation of functional activities with genome sequence data. J Mol Microbiol Biotechnol. 2001;3(1):37\u201362."},{"issue":"Suppl 2","key":"4980_CR13","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1086\/342108","volume":"35","author":"GD Wendel","year":"2002","unstructured":"Wendel GD, Sheffield JS, Hollier LM, Hill JB, Ramsey PS, Sanchez PJ. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis. 2002;35(Suppl 2):S200\u20139.","journal-title":"Clin Infect Dis"},{"key":"4980_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000239106","volume":"39","author":"R Lang","year":"1993","unstructured":"Lang R, Shalit I, Segal J, Arbel Y, Markov S, Hass H, et al. Maternal and fetal serum and tissue levels of ceftriaxone following preoperative prophylaxis in emergency cesarean section. Chemotherapy. 1993;39:77\u201381.","journal-title":"Chemotherapy"},{"issue":"3","key":"4980_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1447-0756.2010.01246.x","volume":"36","author":"O Ozyuncu","year":"2010","unstructured":"Ozyuncu O, Beksac MS, Nemutlu E, Katlan D, Kir S. Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin, and cefixime. J Obstet Gynaecol Res. 2010;36(3):484\u20137.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"4980_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/cid\/civ270","volume":"61","author":"R Tanizaki","year":"2015","unstructured":"Tanizaki R, Nishijima T, Aoki T, et al. High dose oral amoxicillin plus probenecid is highly effective for syphilis in patients with HIV infection. Clin Infect Dis. 2015;61(2):177\u201383.","journal-title":"Clin Infect Dis"},{"key":"4980_CR17","doi-asserted-by":"crossref","unstructured":"Hay PE, Taylor-Robinson D, Waldron S, Goldmeier D. Amoxicillin, syphilis and HIV infection. Lancet. 1990:474\u20135.","DOI":"10.1016\/0140-6736(90)90708-D"},{"issue":"6","key":"4980_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/030006057900700612","volume":"7","author":"Y Onoda","year":"1979","unstructured":"Onoda Y. Clinical evaluation of amoxycillin in the treatment of syphilis. J Int Med Res. 1979;7(6):539\u201345.","journal-title":"J Int Med Res"},{"issue":"2","key":"4980_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ped.12417","volume":"57","author":"H Hori","year":"2015","unstructured":"Hori H, Sato Y, Shitara T. Congenital syphilis presenting as Jarisch-Herxheimer reaction at birth. Pediatr Int. 2015;57(2):299\u2013301. https:\/\/doi.org\/10.1111\/ped.12417.","journal-title":"Pediatr Int"},{"issue":"Suppl 2","key":"4980_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/AOG.0b013e3181e7d065","volume":"116","author":"MW Rac","year":"2010","unstructured":"Rac MW, Greer LG, Wendel GD. Jarisch-Herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis. Obstet Gynecol. 2010;116(Suppl 2):552\u20136. https:\/\/doi.org\/10.1097\/AOG.0b013e3181e7d065.","journal-title":"Obstet Gynecol"},{"key":"4980_CR21","doi-asserted-by":"publisher","unstructured":"Nishijima T, Kawana K, Fukasawa I, Ishikawa N, Taylor MM, Mikamo H, Kato K, Kitawaki J, Fujii T. Effectiveness and Tolerability of Oral Amoxicillin in Pregnant Women with Active Syphilis, Japan, 2010\u20132018. In Press. Emerg Infect Dis. 2020;26(6). https:\/\/doi.org\/10.3201\/eid2606.191300.","DOI":"10.3201\/eid2606.191300"},{"issue":"5","key":"4980_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3201\/eid2305.161936","volume":"23","author":"Y Katanami","year":"2017","unstructured":"Katanami Y, Hashimoto T, Takaya S, Yamamoto K, Kutsuna S, Takeshita N, et al. Amoxicillin and ceftriaxone as treatment alternatives to penicillin for maternal syphilis. Emerg Infect Dis. 2017;23(5):827\u20139. https:\/\/doi.org\/10.3201\/eid2305.161936.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"4980_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1258\/ijsa.2012.012049","volume":"23","author":"C O\u2019Mahony","year":"2012","unstructured":"O\u2019Mahony C, Bradley MG, McKeown J, Arya OP. Treponemicidal levels of amoxicillin can be achieved in cerebrospinal fluid following oral treatment with only 4 g amoxicillin and 2 g probenecid daily in late stage syphilis. Int J STD AIDS. 2012;23(10):758. https:\/\/doi.org\/10.1258\/ijsa.2012.012049.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"4980_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/00007435-198307000-00011","volume":"10","author":"WR Faber","year":"1983","unstructured":"Faber WR, Bos JD, Rietra PJ, Fass H, Van Eijk RV. Treponemicidal levels of amoxicillin in cerebrospinal fluid after oral administration. Sex Transm Dis. 1983;10(3):148\u201350.","journal-title":"Sex Transm Dis"},{"issue":"Suppl","key":"4980_CR25","first-page":"6","volume":"47","author":"O Idsoe","year":"1972","unstructured":"Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis. Bull World Health Organ. 1972;47(Suppl):6\u201313.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"4980_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.clpt.6100126","volume":"81","author":"MA Andrew","year":"2007","unstructured":"Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, et al. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther. 2007;81(4):547\u201356.","journal-title":"Clin Pharmacol Ther"},{"key":"4980_CR27","doi-asserted-by":"crossref","unstructured":"Eagle H, Fleischman R, Musselman A. The effective concentrations of penicillin in vitro and in vivo against streptococci, pneumococci, and Treponema pallidum. J Bacteriol. 1950;59(5):625.","DOI":"10.1128\/jb.59.5.625-643.1950"},{"issue":"5","key":"4980_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF01046715","volume":"34","author":"RD Faulkner","year":"1988","unstructured":"Faulkner RD, Bohaychuk W, Haynes JD, Desjardins RE, Yacobi A, Silber BM. The pharmacokinetics of cefixime in the fasted and fed state. Eur J Clin Pharmacol. 1988;34(5):525\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"4980_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/j.1552-4604.1988.tb03203.x","volume":"28","author":"RD Faulkner","year":"1988","unstructured":"Faulkner RD, Fernandez P, Lawrence G, Sia LL, Falkowski AJ, Weiss AI, et al. Absolute bioavailability of cefixime in man. J Clin Pharmacol. 1988;28(8):700\u20136.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"4980_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/OLQ.0000000000000844","volume":"45","author":"LA Barbee","year":"2018","unstructured":"Barbee LA, Nayak SU, Blumer J, O\u2019Riordan M, Gray W, Zenilman J, Golden MR, Griffiss JM. A phase 1 pharmacokinetic and safety study of extended duration high-dose cefixime for cephalosporin-resistant Neisseria gonorrhoeae in the pharynx. Sex Transm Dis. 2018;45(10):677\u201383.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"4980_CR31","first-page":"6","volume":"24","author":"VV Rafal\u2019skii","year":"2013","unstructured":"Rafal\u2019skii VV, Dovgan EV, Kozyrev Iu V, Gustovarova TA, Khlybova SV, Novoselova AV, et al. The efficacy and safety of cefixime and amoxicillin\/clavulanate in the treatment of asymptomatic bacteriuria in pregnant women: a randomized, prospective, multicenter study. Urologiia. 2013;24(5):6\u20138.","journal-title":"Urologiia"},{"issue":"2","key":"4980_CR32","first-page":"73","volume":"8","author":"LMA Al-Huseini","year":"2016","unstructured":"Al-Huseini LMA, Swadi AA, Swadi SM. Effective cefixime treatment in pregnant women with urinary tract infection. J Chem Pharm Res. 2016;8(2):73\u20138.","journal-title":"J Chem Pharm Res"},{"key":"4980_CR33","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Boletim Epidemiol\u00f3gico de S\u00edfilis. Ano V, #01, 2019. Minist\u00e9rio da Sa\u00fade. ISSN 2358-9450. http:\/\/www.aids.gov.br\/pt-br\/pub\/2019\/boletim-epidemiologico-sifilis-2019. Accessed 1 Nov 2019."},{"key":"4980_CR34","first-page":"248","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Aten\u00e7\u00e3o Integral \u00e0s Pessoas com Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis (IST)","author":"Brasil. Minist\u00e9rio da Sa\u00fade","year":"2019","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Aten\u00e7\u00e3o Integral \u00e0s Pessoas com Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis (IST). Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2019. p. 248. Accessed at: http:\/\/www.aids.gov.br\/pt-br\/pub\/2015\/protocolo-clinico-e-diretrizes-terapeuticas-para-atencao-integral-pessoas-com-infeccoes."},{"key":"4980_CR35","unstructured":"U.S. Department of Health and Human Services. National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf."},{"issue":"11","key":"4980_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1086\/652239","volume":"201","author":"EW Hook 3rd","year":"2010","unstructured":"Hook EW 3rd, Behets F, Van Damme K, Ravelomanana N, Leone P, Sena AC, Martin D, Langley C, McNeil L, Wolff M. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis. 2010;201(11):1729\u201335. https:\/\/doi.org\/10.1086\/652239.","journal-title":"J Infect Dis"},{"key":"4980_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.7326\/0003-4819-114-12-1005","volume":"114","author":"B Rowanowski","year":"1991","unstructured":"Rowanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serological response to treatment of infectious syphilis. Ann Int Med. 1991;114:1005\u20139.","journal-title":"Ann Int Med"},{"key":"4980_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12879-015-1209-0","volume":"15","author":"AC Sena","year":"2015","unstructured":"Sena AC, Zhang XH, Li T, Zheng HP, Yang B, Yang LG, et al. A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking thesignificance of serological non-responsiveness and the serofast state after therapy. BMC Infect Dis. 2015;15:479. https:\/\/doi.org\/10.1186\/s12879-015-1209-0.","journal-title":"BMC Infect Dis"},{"key":"4980_CR39","unstructured":"World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Available from: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241595858\/en\/."},{"key":"4980_CR40","volume-title":"Global Guidance on Criteria and Processes for Validation: Elimination of Mother-to-Child Transmission of HIV and Syphilis","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Global Guidance on Criteria and Processes for Validation: Elimination of Mother-to-Child Transmission of HIV and Syphilis. Geneva: WHO; 2014. ISBN 978 92 4 150588 8."},{"key":"4980_CR41","unstructured":"World Health Organization. Global Health Sector Strategy on Sexually Transmitted Infections 2016\u20132021. Available from: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/ghss-stis\/en\/."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04980-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-04980-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-04980-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T07:42:01Z","timestamp":1625125321000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-04980-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4980"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-04980-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Status:<\/b> Approved<b>Name and contact details of ethics committee(s),<\/b><b>Dates of approval:<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No images or other personal or clinical details of participants will be presented that could compromise anonymity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The principal investigators and co-authors have declared that no competing interests exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}